Research Summary
Inosine pranobex, also known as methisoprinol, is a synthetic antiviral drug that consists of a combination of inosine and dimepranol acedoben (an ester of N,N-dimethylamino-2-propanol and 1-acetylbicyclo[2.2.2]octane-2,3-dicarboxylic acid). It is primarily used for the treatment of viral infections, particularly those caused by certain RNA and DNA viruses such as herpes simplex, varicella-zoster, and human papillomavirus (HPV). Inosine pranobex works by stimulating the body's immune response to viral infections, enhancing the activity of natural killer cells and T lymphocytes. Additionally, it has immunomodulatory effects, including the inhibition of excessive inflammation and the regulation of cytokine production. Inosine pranobex is available in oral tablet or oral suspension forms and is generally well-tolerated, with common side effects including gastrointestinal discomfort and mild allergic reactions. It has been used in various countries for decades and continues to be investigated for its potential therapeutic benefits in treating viral infections and immune-related disorders.
According to DIResearch's in-depth investigation and research, the global Inosine Pranobex market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Inosine Pranobex include Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi, Andr??maco, Yung Shin, Alfasigma S.p.A., Polfarmex, Sanfer, Meprofarm, Novell Pharmaceutical, Aflofarm etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Inosine Pranobex. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Inosine Pranobex market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Inosine Pranobex market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Inosine Pranobex industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Inosine Pranobex Include:
Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi
Andr??maco
Yung Shin
Alfasigma S.p.A.
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm
Inosine Pranobex Product Segment Include:
Tablet
Syrup
Inosine Pranobex Product Application Include:
Immunomodulation
Antiviral
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Inosine Pranobex Industry PESTEL Analysis
Chapter 3: Global Inosine Pranobex Industry Porter's Five Forces Analysis
Chapter 4: Global Inosine Pranobex Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Inosine Pranobex Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Inosine Pranobex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Inosine Pranobex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Inosine Pranobex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Inosine Pranobex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Inosine Pranobex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Inosine Pranobex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Inosine Pranobex Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Inosine Pranobex Market Overview 1.1 Product Definition and Statistical Scope 1.2 Inosine Pranobex Product by Type 1.2.1 Global Inosine Pranobex Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Tablet 1.2.3 Syrup 1.3 Inosine Pranobex Product by Application 1.3.1 Global Inosine Pranobex Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Immunomodulation 1.3.3 Antiviral 1.3.4 Other 1.4 Global Inosine Pranobex Market Revenue and Sales Analysis 1.4.1 Global Inosine Pranobex Market Size Analysis (2019-2030) 1.4.2 Global Inosine Pranobex Market Sales Analysis (2019-2030) 1.4.3 Global Inosine Pranobex Market Sales Price Trend Analysis (2019-2030) 1.5 Inosine Pranobex Market Development Status and Trends 1.5.1 Inosine Pranobex Industry Development Status Analysis 1.5.2 Inosine Pranobex Industry Development Trends Analysis 2 Inosine Pranobex Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Inosine Pranobex Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Inosine Pranobex Market Analysis by Regions 4.1 Inosine Pranobex Overall Market: 2023 VS 2024 VS 2030 4.2 Global Inosine Pranobex Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Inosine Pranobex Revenue and Market Share by Region (2019-2024) 4.2.2 Global Inosine Pranobex Revenue Forecast by Region (2025-2030) 4.3 Global Inosine Pranobex Sales and Forecast Analysis (2019-2030) 4.3.1 Global Inosine Pranobex Sales and Market Share by Region (2019-2024) 4.3.2 Global Inosine Pranobex Sales Forecast by Region (2025-2030) 4.4 Global Inosine Pranobex Sales Price Trend Analysis (2019-2030) 5 Global Inosine Pranobex Market Size by Type and Application 5.1 Global Inosine Pranobex Market Size by Type 5.1.1 Global Inosine Pranobex Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Inosine Pranobex Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Inosine Pranobex Market Size by Application 5.2.1 Global Inosine Pranobex Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Inosine Pranobex Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Inosine Pranobex Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Inosine Pranobex Market Size by Type 6.3.1 North America Inosine Pranobex Sales by Type (2019-2030) 6.3.2 North America Inosine Pranobex Revenue by Type (2019-2030) 6.4 North America Inosine Pranobex Market Size by Application 6.4.1 North America Inosine Pranobex Sales by Application (2019-2030) 6.4.2 North America Inosine Pranobex Revenue by Application (2019-2030) 6.5 North America Inosine Pranobex Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Inosine Pranobex Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Inosine Pranobex Market Size by Type 7.3.1 Europe Inosine Pranobex Sales by Type (2019-2030) 7.3.2 Europe Inosine Pranobex Revenue by Type (2019-2030) 7.4 Europe Inosine Pranobex Market Size by Application 7.4.1 Europe Inosine Pranobex Sales by Application (2019-2030) 7.4.2 ? Europe Inosine Pranobex Revenue by Application (2019-2030) 7.5 Europe Inosine Pranobex Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Inosine Pranobex Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Inosine Pranobex Market Size by Type 8.3.1 China Inosine Pranobex Sales by Type (2019-2030) 8.3.2 China Inosine Pranobex Revenue by Type (2019-2030) 8.4 China Inosine Pranobex Market Size by Application 8.4.1 China Inosine Pranobex Sales by Application (2019-2030) 8.4.2 China Inosine Pranobex Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Inosine Pranobex Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Inosine Pranobex Market Size by Type 9.3.1 APAC (excl. China) Inosine Pranobex Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Inosine Pranobex Revenue by Type (2019-2030) 9.4 APAC (excl. China) Inosine Pranobex Market Size by Application 9.4.1 APAC (excl. China) Inosine Pranobex Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Inosine Pranobex Revenue by Application (2019-2030) 9.5 APAC (excl. China) Inosine Pranobex Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Inosine Pranobex Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Inosine Pranobex Market Size by Type 10.3.1 Latin America Inosine Pranobex Sales by Type (2019-2030) 10.3.2 Latin America Inosine Pranobex Revenue by Type (2019-2030) 10.4 Latin America Inosine Pranobex Market Size by Application 10.4.1 Latin America Inosine Pranobex Sales by Application (2019-2030) 10.4.2 Latin America Inosine Pranobex Revenue by Application (2019-2030) 10.5 Latin America Inosine Pranobex Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Inosine Pranobex Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Inosine Pranobex Market Size by Type 11.3.1 Middle East & Africa Inosine Pranobex Sales by Type (2019-2030) 11.3.2 Middle East & Africa Inosine Pranobex Revenue by Type (2019-2030) 11.4 Middle East & Africa Inosine Pranobex Market Size by Application 11.4.1 Middle East & Africa Inosine Pranobex Sales by Application (2019-2030) 11.4.2 Middle East & Africa Inosine Pranobex Revenue by Application (2019-2030) 11.5 Middle East & Africa Inosine Pranobex Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Inosine Pranobex Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Inosine Pranobex Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Inosine Pranobex Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Inosine Pranobex Average Sales Price by Manufacturers (2020-2024) 12.2 Inosine Pranobex Competitive Landscape Analysis and Market Dynamic 12.2.1 Inosine Pranobex Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Newport Pharmaceuticals 13.1.1 Newport Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Newport Pharmaceuticals Inosine Pranobex Product Portfolio 13.1.3 Newport Pharmaceuticals Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Gedeon Richter 13.2.1 Gedeon Richter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Gedeon Richter Inosine Pranobex Product Portfolio 13.2.3 Gedeon Richter Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Mochida 13.3.1 Mochida Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Mochida Inosine Pranobex Product Portfolio 13.3.3 Mochida Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Sanofi 13.4.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Sanofi Inosine Pranobex Product Portfolio 13.4.3 Sanofi Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Andr??maco 13.5.1 Andr??maco Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Andr??maco Inosine Pranobex Product Portfolio 13.5.3 Andr??maco Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Yung Shin 13.6.1 Yung Shin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Yung Shin Inosine Pranobex Product Portfolio 13.6.3 Yung Shin Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Alfasigma S.p.A. 13.7.1 Alfasigma S.p.A. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Alfasigma S.p.A. Inosine Pranobex Product Portfolio 13.7.3 Alfasigma S.p.A. Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Polfarmex 13.8.1 Polfarmex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Polfarmex Inosine Pranobex Product Portfolio 13.8.3 Polfarmex Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Sanfer 13.9.1 Sanfer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Sanfer Inosine Pranobex Product Portfolio 13.9.3 Sanfer Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.10 Meprofarm 13.10.1 Meprofarm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Meprofarm Inosine Pranobex Product Portfolio 13.10.3 Meprofarm Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.11 Novell Pharmaceutical 13.11.1 Novell Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Novell Pharmaceutical Inosine Pranobex Product Portfolio 13.11.3 Novell Pharmaceutical Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.12 Aflofarm 13.12.1 Aflofarm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Aflofarm Inosine Pranobex Product Portfolio 13.12.3 Aflofarm Inosine Pranobex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Inosine Pranobex Industry Chain Analysis 14.2 Inosine Pranobex Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Inosine Pranobex Typical Downstream Customers 14.4 Inosine Pranobex Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support